Article thumbnail

Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe:a phase II clinical trial

By Siv Fonnes, Barbara Juliane Holzknecht, Magnus Arpi and Jacob Rosenberg
Topics: /dk/atira/pure/researchoutput/pubmedpublicationtype/D016428, Journal Article
Publisher: 'Springer Science and Business Media LLC'
Year: 2019
DOI identifier: 10.1038/s41598-019-43151-4
OAI identifier:

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.